OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

Abroad (travel likely)RecruitingPHASE4

Conditions

Breast Cancer · Estrogen Receptor Positive Tumor · HER2-negative Breast Cancer · Premenopausal Breast Cancer · Node-positive Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Gangnam Severance Hospital, Seoul, Korea, South Korea
Contact: Study coordinator (Sung Gwe Ahn, MD, PhD) · asg2004@yuhs.ac · 0220193370
Study coordinator · asg2004@yuhs.ac
Contact: Principal Investigator (Sung Gwe Ahn, MD.,PH.D.)
Seoul National University Hospital, Seoul, South Korea
Contact: Study coordinator (Hyeoung Gon Moon)

Study leads

Sung Gwe Ahn, M.D.,Ph.D.
Principal Investigator
Gangnam Severance Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study

Breast Cancer

Abroad (travel likely)RecruitingPHASE4

Pittsburgh, United States

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation · HER2- Negative Breast Cancer · Hormone Receptor Positive Tumor

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Beverly Hills, United States

Opioid-free Anaesthesia in Breast Cancer Surgery

Breast Cancer · Anesthesia · Pain, Postoperative

Abroad (travel likely)Recruiting

Ioannina, Greece

The Effect of Mindfulness-Based Breathing Exercises on Symptom Control

Breast Cancer

Abroad (travel likely)Recruiting

Elâzığ, Turkey (Türkiye)